دورية أكاديمية

Randomized phase II BGOG/ENGOT-cx1 study of paclitaxel-carboplatin with or without nintedanib in first-line recurrent or advanced cervical cancer

التفاصيل البيبلوغرافية
العنوان: Randomized phase II BGOG/ENGOT-cx1 study of paclitaxel-carboplatin with or without nintedanib in first-line recurrent or advanced cervical cancer
المؤلفون: Vergote, I., Van Nieuwenhuysen, E., Casado, A., Laenen, A., Lorusso, D., Braicu, E.I., Guerra-Alia, E., Zola, P., Wimberger, P., Debruyne, P.R., Falcó, E., Ferrero, A., Muallem, M.Z., Kerger, J., García-Martinez, E., Pignata, S., Sehouli, J., Van Gorp, T., Gennigens, C., Rubio, M.J.
المصدر: In Gynecologic Oncology July 2023 174:80-88
قاعدة البيانات: ScienceDirect
الوصف
تدمد:00908258
DOI:10.1016/j.ygyno.2023.04.028